Management of Thalassemias
Author:
Publisher
Springer International Publishing
Link
http://link.springer.com/content/pdf/10.1007/978-3-319-30352-9_5
Reference69 articles.
1. Anderson LJ, Holden S, Davis B, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J. 2001;22(23):2171–9.
2. Anderson LJ, Westwood MA, Holden S, et al. Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance. Br J Haematol. 2004;127(3):348–55.
3. Ang AL, Shah F,BD, et al. Deferiprone is associated with lower Serum Ferritin (SF) relative to Liver Iron Concentration (LIC) than deferoxamine and deferasirox-implications for clinical practice. Blood. 2010;116:4246.
4. Angelucci E. Hematopoietic stem cell transplantation in thalassemia. Hematol Am Soc Hematol Educ Program. 2010;2010:456–62.
5. Angelucci E, Baronciani D. Allogeneic stem cell transplantation for thalassemia major. Haematologica. 2008;93(12):1780–4.
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Health‐related quality of life with standard and curative therapies in thalassemia: A narrative literature review;Annals of the New York Academy of Sciences;2024-01-25
2. Adherence to Iron Chelation Therapy among Adults with Thalassemia: A Systematic Review;Hemoglobin;2022-07-04
3. The safety and acceptability of twice‐daily deferiprone for transfusional iron overload: A multicentre, open‐label, phase 2 study;British Journal of Haematology;2021-12-21
4. Concordance with comprehensive iron assessment, hepatitis A vaccination, and hepatitis B vaccination recommendations among patients with sickle cell disease and thalassaemia receiving chronic transfusions: an analysis from the Centers for Disease Control haemoglobinopathy blood safety project;British Journal of Haematology;2021-08-24
5. A systematic review of quality of life in sickle cell disease and thalassemia after stem cell transplant or gene therapy;Blood Advances;2021-01-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3